Observational study of newly detected gastric cancer after intensive esophagogastroduodenoscopy (I-EGD) in high-risk populations

Observational study of newly detected gastric cancer after intensive esophagogastroduodenoscopy (I-EGD) in high-risk populations - Observational study of newly detected gastric cancer after intensive esophagogastroduodenoscopy (I-EGD) in high-risk populations

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061466

Enrollment

4400

Registered

2026-05-11

Start date

2024-02-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were enrolled in the EGC Detection Trial.

Exclusion criteria

Exclusion criteria: 1. Patients who did not complete protocol-defined intensive esophagogastroduodenoscopy (I-EGD) using white light imaging (WLI) and second-generation narrow band imaging (2G-NBI) in the EGC Detection Trial. 2. Patients for whom information on post-I-EGD esophagogastroduodenoscopy is unavailable. 3. Patients who opted out of the use of their clinical information for this study.

Design outcomes

Primary

Measure	Time frame
Cumulative incidence of newly detected gastric cancer after I-EGD. The date of I-EGD will be defined as the time origin, and the first diagnosis of newly detected gastric cancer after I-EGD will be defined as the event.	—

Secondary

Measure	Time frame
Key secondary outcomes include subgroup-specific cumulative incidence of newly detected gastric cancer after I-EGD, clinical and clinicopathological characteristics of patients and lesions with newly detected gastric cancer, treatment modality and curability of endoscopic resection, and retrospective detectability of newly detected gastric cancer on the preceding surveillance EGD images.	—

Countries

Japan

Contacts

Public ContactNaohiro Yoshida

Ishikawa Prefectural Central Hospital Department of Gastroenterology

naohilowg@gmail.com076-237-8211(81-76-237-8211)

Outcome results